Monoclonal Antibody Treatment
ChristianaCare offers monoclonal antibody treatment (mAb), Bebtelovimab, to help those at high risk of complications from COVID-19
Your body naturally makes antibodies to fight infection. However, your body may not have antibodies designed to recognize a new virus like the one that causes COVID-19. Monoclonal antibodies are made in a laboratory to fight a particular infection based on natural antibodies against COVID-19. The mAb treatment can help patients who are at high risk for severe symptoms or hospitalization from COVID-19. In addition, they can help shorten the course of illness from COVID-19 and prevent hospitalization.
Monoclonal antibodies are not a cure for COVID-19.
This investigational treatment is not authorized for use in patients:
- who are hospitalized due to COVID-19; or
- who need oxygen therapy due to COVID-19; or
- who need increased oxygen due to COVID-19 or who are on chronic oxygen therapy due to a non-COVID-19 health problem.